| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |